Case reports

Hydroa vacciniforme lymphoproliferative disorder:a case report

Expand
  • 1a. Department of Pathology, 1b. Department of Dermatology, 1c. Department of Hematology, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China
    2. Department of Dermatology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China

Received date: 2023-01-02

  Online published: 2024-03-18

Abstract

In this study, we report a case of hydroa vacciniforme lymphoproliferative disorder (HVLPD). The patient, who was 21 years old at the time of initial consultation,suffering from recurrent papules, vesicular rashes, bleeding and black scabs on the neck, face and trunk. Serum EBV-DNA was significantly increased (2.88×107 copies/mL). The patient underwent skin biopsies twice within 2 years. The pathology of the first skin biopsy showed partial degeneration and loosening of the epidermal stratum spinosum, intraepidermal blister formation, partial epidermal detachment, and multifocal small abscesses seen in the blisters and stratum spinosum. Patchy infiltration of small lymphocytes, plasma cells, histiocytes, and eosinophils in the dermis, with no significant atypia of lymphocytes, EBER in situ hybridization was negative, which made it difficult to make a definitive diagnosis on pathology. The pathology of the second skin biopsy showed blisters visible within the patient's epidermis, and atypical lymphoid cells infiltrate around the hair follicles, sweat glands and blood vessels in the dermis. The immunohistochemical analysis indicated that lymphoid cells were positive for CD3, CD5, CD4, CD8, granzyme B and TIA-1, while CD56 and Perforin were negative, and the proliferation rate of Ki-67 was approximately 10%. EBER was positive by in situ hybridization consistent with clinicopathologic features of HVLPD. More than 1 year after receiving symptomatic treatment, the patient's rash worsened, with sometimes fever and left eyelid edema. The third skin biopsy performed in the other hospital showed that atypical lymphoid cells infiltrated the subcutaneous adipose tissue, and the proliferation rate of Ki-67 was 60%. The disease progressed to EBER-positive T-cell lymphoma. After 2 courses of chemotherapy with gemcitabine, cisplatin, dexamethasone and pegaspargase, the patient's edema subsided and the rash healed. This report demonstrates the clinical and pathologic features of the disease during its evolution and progression, with a view to enriching its diagnostic and therapeutic experience.

Cite this article

ZHU Xia, JIN Jingjing, WANG Xin, MIAO Fei, MA Jiexian, ZHANG Jiechen, XIAO Li . Hydroa vacciniforme lymphoproliferative disorder:a case report[J]. Journal of Diagnostics Concepts & Practice, 2023 , 22(06) : 593 -597 . DOI: 10.16150/j.1671-2870.2023.06.013

References

[1] GUPTA G, MAN I, KEMMETT D. Hydroa vacciniforme: A clinical and follow-up study of 17 cases[J]. J Am Acad Dermatol, 2000,42:208-213.
[2] QUINTANILLA-MARTINEZ L K Y, KO Y H, KIMURA H, et al. Hydroa vacciniforme-like lymphoproliferative disorder[M]// SWERDLOWS H, CAMPOE, HARRISN L, et al. WHO Classification of Tumours of Haematopoie-tic and Lymphoid Tissue. 4th ed. Lyon,France: IARC, 2017,360-362.
[3] IWATSUKI K, SATOH M, YAMAMOTO T, et al. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders[J]. Arch Dermatol, 2006, 142(5):587-595.
[4] QUINTANILLA-MARTINEZ L, RIDAURA C, NAGL F, et al. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma[J]. Blood, 2013, 122(18):3101-3110.
[5] XIE Y, WANG T, WANG L. Hydroa vacciniforme-like lymphoproliferative disorder: A study of clinicopathology and whole-exome sequencing in Chinese patients[J]. J Dermatol Sci, 2020, 99(2):128-134.
[6] MIYAKE T, YAMAMOTO T, HIRAI Y, et al. Survival rates and prognostic factors of Epstein-Barr virus-asso-ciated hydroa vacciniforme and hypersensitivity to mosquito bites[J]. Br J Dermatol, 2015, 172(1):56-63.
[7] GRU A A, JAFFE E S. Cutaneous EBV-related lymphoproliferative disorders[J]. Semin Diagn Pathol, 2017, 34(1):60-75.
[8] 白玄业, 李文才, 王冠男, 等. 种痘水疱病样淋巴组织增生性疾病11例临床病理分析[J]. 临床与实验病理学杂志, 2018, 34(07):764-768.
  BAI X Y, LI W C, WANG G N, et al. Clinicopathological analysis of 11 cases of hydroa vacciniforme-like lymphoproliferative disease[J]. Chin J Clin Exp Pathol, 2018, 34(07):764-768.
[9] LIU Y, MA C, WANG G, et al. Hydroa vacciniforme-like lymphoproliferative disorder: Clinicopathologic study of 41 cases[J]. J Am Acad Dermatol, 2019, 81(2):534-540.
[10] HAN B, HUR K, OHN J, et al. Hydroa vacciniforme-like lymphoproliferative disorder in Korea[J]. Sci Rep, 2020, 10(1):19294.
[11] 王新华, 梁远征, 周志远, 等. 种痘水疱病样淋巴组织增殖性疾病18例临床分析[J]. 郑州大学学报(医学版), 2020, 55(02):166-172.
  WANG X H, LIANG Y Z, ZHOU Z Y, et al. Clinical analysis of 18 patients with hydroa vacciniforme-like lymphoproliferative disorder[J]. J ZHENGZHOU UNIVERSITY (MEDICAL SCIENCES), 2020, 55(02):166-172.
[12] 周小鸽, 张燕林, 谢建兰, 等. 种痘样水疱病的临床病理特点及性质分析[J]. 临床与实验病理学杂志, 2017, 33(5):544-546.
  ZHOU X G, ZHANG Y L, XIE J L, et al. Analysis of clinical pathological characteristics and properties of hydroa vacciniforme[J]. Chin J Clin Exp Pathol, 2017, 33(5):544-546.
[13] CHEN C C, CHANG K C, MEDEIROS L J, et al. Hydroa vacciniforme and hydroa vacciniforme-like lymphoprolife-rative disorder: a spectrum of disease phenotypes associa-ted with ultraviolet irradiation and chronic Epstein-Barr virus infection[J]. Int J Mol Sci, 2020, 21(23):9314.
[14] XUE R, ELBENDARY A, LIU H, et al. Hydroa vaccini-forme-like lymphoma: clinicopathological description, treatment and outcome[J]. J Am Acad Dermatol, 2021, 85(3):752-755.
Outlines

/